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Abstract
The biofilm matrix, composed of exopolysaccharides, proteins, nucleic acids and lipids, plays a well-known role as a defence
structure, protecting bacteria from the host immune system and antimicrobial therapy. However, little is known about its
responsibility in the interaction of biofilm cells with host tissues. Staphylococcus aureus, a leading cause of biofilm-
associated chronic infections, is able to develop a biofilm built on a proteinaceous Bap-mediated matrix. Here, we used the
Bap protein as a model to investigate the role that components of the biofilm matrix play in the interaction of S. aureus with
host cells. The results show that Bap promotes the adhesion but prevents the entry of S. aureus into epithelial cells. A broad
analysis of potential interaction partners for Bap using ligand overlayer immunoblotting, immunoprecipitation with purified
Bap and pull down with intact bacteria, identified a direct binding between Bap and Gp96/GRP94/Hsp90 protein. The
interaction of Bap with Gp96 provokes a significant reduction in the capacity of S. aureus to invade epithelial cells by
interfering with the fibronectin binding protein invasion pathway. Consistent with these results, Bap deficient bacteria
displayed an enhanced capacity to invade mammary gland epithelial cells in a lactating mice mastitis model. Our
observations begin to elucidate the mechanisms by which components of the biofilm matrix can facilitate the colonization
of host tissues and the establishment of persistent infections.
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Introduction
Staphylococcus aureus is a regular commensal of the skin of animals
and human population and it persistently colonizes the anterior
nares of around 25% of human adults [1]. S. aureus is harmless in
these locations, but it turns into an extremely threatening
pathogen when it traverses the epithelial barrier and gains access
to internal tissues from where it can infect almost any organ and
cause a broad spectrum of infections including abscesses,
pneumonia, endocarditis, osteomyelitis, sepsis and infections
associated with foreign-body implants [2]. Once in the internal
tissue, S. aureus remains mainly extracellular, in the interstitial
space between the cells [3,4], where bacteria encounter cellular,
humoral and complement compounds of the host innate immune
system. To succeed in this environment, S. aureus produces a large
variety of virulence factors that mediate cell and tissue adhesion
(surface proteins), contribute to tissue damage and spreading
(proteases, coagulase, DNAse, lipases, toxins) and protect bacteria
against the host immune defense system (superantigens) [5,6]. In
some cases, S. aureus proliferates producing bacterial aggregates
that grow encased in a self-produced extracellular polymeric
matrix, known as a biofilm [7–11]. Based on the susceptibility of
the biofilm matrix to the disaggregation with glycoside hydrolases
(dispersin B), proteases or DNAse, it is recognized that the S. aureus
biofilm matrix can be made of exopolysaccharides, proteins and
DNA [12–17]. The exopolysaccharidic biofilm matrix is composed
of a polymer of poly-N-acetyl-b-(1–6)-glucosamine, termed poly-
saccharide intercellular adhesin (PIA) or poly-N-acetylglucosamine
(PNAG) [18–21]whereas the proteinaceous biofilm matrix can be
assembled with different surface proteins, namely Bap, FnBPs,
SasG and Protein A [16,17,22–26].
The first example of a surface protein able to induce biofilm
development was Bap. It is a large protein of 2,276-aminoacids
with a series of identical repeats of 86 amino acids that accounts
for more than half of the protein [22], and two canonical calcium
binding EF-hand motifs able to control Bap functionality in
response to the calcium present in the growth media [27]. The bap
gene in S. aureus was initially identified in a mobile pathogenicity
island (SaPIbov2) whose mobility depends on the activity of a self-
encoded recombinase protein [28]. So far, the bap gene has never
been found in S. aureus human isolates. However, a bap ortholog
gene is present in the core genome of several coagulase-negative
staphylococcal species that are frequent colonizers of human skin
[29].All the S. aureus strains harbouring the bap gene are strong
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biofilm producers and Bap-mediated biofilm formation process
occurs independently of the presence of the PIA/PNAG
exopolysaccharide [30].A particularly interesting issue concerning
this Bap assembled matrix is that functionally related proteins
homologous to Bap exist in many phylogenetically unrelated
bacteria including Enterococcus faecalis, Acinetobacter baumanii, Pseudo-
monas aeruginosa, Salmonella enteritidis, Lactobacillus reuteri, Bordetella
pertussis and Escherichia coli (for a review see [31]). All the Bap
homologous proteins show high molecular weight, contain a core
domain of repeats and promote bacterial aggregation and biofilm
development.
It is currently clear that matrix production and subsequent
biofilm formation is very often associated with the establishment of
persistent infections due to the highly resistant nature of the
embedded bacteria to both the host immune defences and the
antimicrobial therapy. In this respect, several studies have
demonstrated that the PIA/PNAG matrix aids S. aureus in the
evasion of host immune defences by protecting bacteria from
macrophage phagocytosis and attenuating host proinflammatory
responses [32–35].Furthermore, phenol-soluble modulins (PSMs)
surfactant peptides secreted to the biofilm matrix of S. aureus act as
biofilm structuring factors but also have multiple functions in
immune system evasion [35,36].
In addition to its protecting role, it is feasible to envision that the
biofilm matrix may mask important bacterial surface antigens, and
in this context, the interaction between bacteria inside the biofilm
and the host might rely on the specific binding of extracellular
matrix components to host cell receptors. Accordingly, various
studies have proposed a role of the Bap-mediated biofilm matrixes,
including BapA of S. Enteritidis, Esp of E. faecalis, Lsp of L. reuteri
and Bap of A. baumanii, in the adhesion to host cells [37–40]. With
regard to Bap of S. aureus, we have previously shown that the
presence of a Bap-mediated biofilm matrix interferes with the
binding of several S. aureus adhesins (fibronectin-binding protein
and clumping factor) to their targets (fibrinogen and fibronectin) in
host tissues [41]. Despite this masking effect caused by the Bap
matrix, S. aureus strains producing Bap display an enhanced
capacity to colonize and persist in the mammary gland
[30].However, the underlying molecular mechanisms of the
interaction between the Bap related proteins and eukaryotic cells
remain unknown.
In this study, we used the staphylococcal Bap mediated matrix
as a model to investigate the role that components of the biofilm
matrix play in the interaction with host cells. Our results revealed
that Bap enhances the adhesion but inhibits the entry of S. aureus
into the epithelial cells. We also identified a direct interaction
between Bap and the Gp96 chaperone protein from host cells.
Binding of Bap to Gp96 was responsible for the inhibition of
bacterial invasion into nonprofessional phagocytic cells by
interfering with the fibronectin-binding protein mediated inter-
nalization pathway. Overall, our results reveal new facets of the
roles that the biofilm matrix plays during the establishment of
persistent infections.
Results
Bap promotes adhesion but inhibits the entry of S. aureus
into epithelial cells
To analyze the involvement of the Bap matrix on the adherence
capacity of S. aureus, we tested the ability of S. aureus V329 strain and
Dbap mutant to adhere to two different cell lines, a bovine mammary
epithelial (MAC-T)and a human hepatocyte (Hep-3B) cell line. The
bacterial inoculum used in cell assays came from an overnight
culture in which S. aureus V329 strain aggregated at the bottom of the
tube and also formed a Bap-dependent biofilm adhered to the glass
wall, whereas Dbap mutant grew planktonically (data not shown).
The results revealed that the V329 strain adhered 4-fold more
efficiently (P,0.05) than the Dbap mutant to both cell lines
(Figure 1A). It is worth noting that Bap-negative bacteria also
showed a reduce capacity to adhere to a HEK293 cell line, despite
the fact that these differences passed unnoticed in a previous study of
our group [41].We then compared the adhesion of a natural bap-
negative strain, S. aureus Newman, and its isogenic derivative
containing a chromosomal copy of the bap gene (S. aureus New-
man_Bap) [27]. S. aureus Newman_Bap showed a5 times (P,0.05)
higher capacity to adhere to both MAC-T and Hep-3B cell lines
than its parental bap-deficient S. aureus Newman strain (Figure 1B).
These results indicated that the presence of Bap enhances the
capacity of S. aureus to bind to epithelial cells, but they did not answer
the question as to whether the Bap protein was sufficient to promote
adhesion. To elucidate this point, the Bap protein was expressed in a
heterologous surrogate bacterium, Enterococcus faecalis and its
adherence capacity was tested. E. faecalis producing the Bap protein
adhered significantly more efficiently to both MAC-T and Hep-3B
cell lines (P,0.05) than the corresponding wild type strain
(Figure 1B). Taken together, these results demonstrated that the
Bap protein confers the capacity to adhere to epithelial cells.
Next, taking into account that S. aureus strain V329 invaded
human embryonic kidney cells (HEK293)less efficiently than its
corresponding Bap-deficient strain [41],we decided to test whether
Bap could also block S. aureus entry in our cellular models, MAC-T
and Hep-3B cells. Quantification of intracellular bacteria, after
invasion assays with S. aureus V329 and Dbap revealed that S. aureus
Dbap, despite its deficiency in the adhesion capacity to epithelial
cells, was able to invade more efficiently MAC-T and Hep-3B cells
than the wild type strain(Figure 1C). To ensure that inhibition of S.
aureus entry was due to the presence of Bap rather than to the
presence of a biofilm matrix, we compared the invasion capacity of
S. aureus V329 and Dbap strains complemented with a plasmid
carrying the icaADBC operon (pSC18) as well as S. aureus ISP479r,
a strain that constitutively produces large amounts of PIA/PNAG
exopolysaccharide, and its isogenic Dica mutant. The results
Author Summary
Staphylococcus aureus is a pathogen responsible for a wide
variety of infections, some of which become chronic due
to the capacity of this bacteria to form multicellular
communities that grow embedded in a self-produced
extracellular matrix, referred to as biofilms. Numerous
evidences have demonstrated that growing in the biofilm
protects bacteria from the immune system and antimicro-
bial treatments. However, less attention has been paid to
the role that the biofilm extracellular matrix plays in the
interaction with host cells. Here, we investigate this issue
through the use of the proteinaceous biofilm matrix
assembled by the Bap protein as a model. Our results show
that the Bap biofilm matrix triggers the adhesion to
epithelial cells. After adhesion, Bap binds directly to the
host receptor Gp96 and this interaction inhibits the entry
of the bacteria into the cells by interfering with the
fibronectin-binding protein mediated invasion pathway.
As a result, the expression of Bap decreased cell invasion
and increased bacterial persistence in lactating mice
mammary glands. Thus, our findings revealed a dual role
for the Bap-dependent biofilm matrix during the estab-
lishment of persistent infections, promoting adhesion of S.
aureus to epithelial cells and impairing host cell invasion.
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showed that the presence of the PIA/PNAG matrix does not have
any effect on the capacity of bacteria to invade epithelial cells
(Supplementary Figure S1).
Taken together, these results showed that the Bap-mediated
matrix promotes bacterial adhesion to epithelial cells, and on the
other hand, interferes with S. aureus cell entry.
Identification of Gp96 as the ligand for Bap
We then aimed to identify putative host cell receptors
interacting with Bap by means of a ligand overlay approach.
MAC-T and Hep-3B total cell extracts were separated by SDS-
polyacrylamide gel electrophoresis, transferred onto a nitrocellu-
lose membrane and incubated in the presence of purified
recombinant Bap protein containing a 6xHistidine tag replacing
the LPXTG motif. Then, proteins that bound specifically to Bap
were detected by probing the membrane with an anti-Bap serum.
A Coomassie blue stained gel of the total membrane protein
profile of each strain is shown for reference (Figure 2A). We
focused on Bap-reactive bands that were present in both cell
extracts and absent when the membranes were not incubated
with the Bap protein (Figure 2B). A prominent band in the range
of ,100 kDa was apparent in both MAC-T and Hep-3B cell
extracts. To exclude that the 6xhistidine tag present in the
recombinant Bap protein could be responsible for the interaction
with the eukaryotic protein, we performed a similar ligand
overlayer assay using the unrelated6xHis tagged dispersin
protein. As expected, no specific bands reacting with the cell
extracts were detected when this protein was used as a bait (data
not shown).
To determine the identity of the ,100 kDa Bap binding
protein, the region corresponding to the location of the ,100 kDa
band was excised from a parallel Coomassie stained gel and this
sample was subject to trypsin digestion and MALDI-TOF analysis
followed by peptide mass fingerprinting that was compared with
the human proteome. The results showed that the protein band
corresponded to the endoplasmic reticulum chaperone Gp96
(GRP94), a member of the Hsp90 family of molecular chaperones
[42,43].
Gp96 is expressed at the cell surface of MAC-T and Hep-
3B cells
Although Gp96 is recognized as an endoplasmic reticulum
chaperon for Toll-like receptors [44], numerous evidences indicate
that it is also expressed on the plasma membrane of different cell
types [45–55].Thus, we decided to analyze whether Gp96 protein
is expressed at the cell surface of MAC-T and Hep-3B cells. As a
negative control, we also included in the assay two cell lines (Vero
and GPC-16) that have been previously shown to poorly express
extracellular Gp96 [52]. Firstly, we confirmed the expression of
Gp96 in whole MAC-T and Hep-3B cell extracts by immuno-
blotting using anti-Gp96 antibodies (data not shown). Secondly,
we investigated if Gp96 was localized in the plasma membrane of
MAC-T and Hep-3B cells, by means of labelling surface exposed
proteins of intact cells using the membrane-impermeable biotiny-
lation reagent sulpho-N-hydroxysuccinimide (NHS) biotin (Pierce).
After harvesting the cells, the biotinylated proteins were purified
on streptavidine-beads. Upon reduction, the biotinylated proteins
were released from the beads and analyzed by western-blot using
anti-Gp96 antibodies. The results revealed the presence of Gp96
in the biotinylated protein fraction of MAC-T and Hep-3B cells.
Accordingly, a faint band was detected in Vero and GPC-16 cells.
In addition, to verify that membrane impermeability was not
disrupted during the assay and exclude that cytoplasmic Gp96
could be labeled during the experiment, the biotinylated protein
fractions were interrogated using anti-a-catenin antibodies. The
absence of a-catenin, an abundant protein in the cytoplasm,
confirmed that the biotinylated fraction did not contain cytoplas-
mic proteins (Figure 3A).
Lastly, we used immunofluorescence staining to localize Gp96
distribution at the cell surface. Nonpermeabilised MAC-T, Hep-
3B, Vero and GPC-16 cells were incubated with polyclonal anti-
Figure 1. A) Effect of Bap expression in S. aureus adherence to
epithelial cells. Adhesion of S. aureus V329 wild type (Wt) and Dbap
mutant to the bovine mammary gland epithelial cells MAC-T and to
human hepathocytes Hep-3B. B) Adhesion of S. aureus Newman wild
type (Wt), S. aureus Newman expressing Bap (Bap+), E. faecalis 23 wild
type (Wt) and E. faecalis expressing Bap (Bap+) to MAC-T and Hep-3B
epithelial cells. After 1 h of infection, cells were lysed and cell extracts
were vigorously vortexed for 2 min. Bacterial adhesion was measured
by CFU counts. Increase in adhesion was statistically significant (p
value,0,05) in all comparisons shown. C)Effect of Bap expression in S.
aureus entry into MAC-T and Hep-3B epithelial cells. Bacterial invasion
was measured by CFU count after gentamicin assay. Experiments were
performed in triplicate and repeated four times for each cell line.
doi:10.1371/journal.ppat.1002843.g001
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Gp96 followed by incubation with a secondary antibody conjugated
with Alexa-488. Then, cells were permeabilized and F-actin was
labelled with Alexa-Fluor 647-phalloidin. In agreement with
previous results, Gp96 was clearly detected at the cell surface of
nonpermeabilized MAC-T and Hep-3B cells whereas it was absent
from the cell surface of GPC-16 and Vero cells (Figure 3B).
Figure 2. Identification of Gp96 as a Bap cellular receptor by a ligand overlayer assay. A) Total protein extracts from MAC-T and Hep-3B
cells were separated on a SDS gel, transferred to a nitrocellulose membrane by western-blotting and probed with/without pure Bap protein (50 mg/
ml). B) Bound Bap protein was detected with polyclonal anti-Bap antibodies (a-Bap). A ,100 kDa band reacting with anti-Bap antibodies is shown by
the arrow. This protein was identified by MALDI-TOF analysis of the comigrating band on a Coomasie blue stained gel as Gp96.
doi:10.1371/journal.ppat.1002843.g002
Figure 3. Gp96 is expressed at the cell surface of MAC-T and Hep-3B cells. A) Western-blot analysis of Gp96 expressed at the cell surface.
Surface exposed proteins (SF-extract) of MAC-T, Hep-3B, Vero and GPC-16 cells were labeled with sulpho-N-hydroxysuccinimide (NHS) biotin and
purified using streptavid in columns. Captured proteins were separated in 10% SDS gel, transferred onto a nitrocellulose membrane and probed with
anti-Gp96. To control membrane impermeability, a-catenin was detected from the surface proteins (SF-extract) using anti-a-catenin antibodies,
whose specificity was verified using total cell extracts (T-extract). B) Cellular localization of Gp96. The cellular distribution of Gp96 was analyzed by
immunofluorescence using nonpermeabilized MAC-T, Hep-3B, Vero and GPC-16 cells labelled with anti-Gp96 (Gp96 ex.), phalloidin (actin) and DAPI.
doi:10.1371/journal.ppat.1002843.g003
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Gp96 is a ligand for Bap on intact S. aureus
One caution of the ligand overlay assay is that proteins
presented in non-native conformations may interact in artificial
ways with a ligand and lead to the detection of ‘‘false positive’’
interactions. Several lines of evidences were used to indepen-
dently verify that Gp96 is a ligand of Bap. First, we assessed the
interaction of purified Bap with recombinant Gp96 by coimmu-
noprecipitation using anti-Bap polyclonal antibodies, and as a
result, we found a band corresponding to Gp96 after immuno-
precipitation of the complex (Figure 4A). Second, we analyzed
the binding of Gp96 to live, intact S. aureus bacteria. For that, S.
aureusV329 (Bap+) and it isogenic S. aureus Dbap mutant were
incubated with recombinant Gp96 protein. Binding of Gp96 to S.
aureus was detected by western-blot using monoclonalanti-Gp96
antibodies. As shown in figure 4B, the presence of Gp96 was only
detected in cell extracts of S. aureus producing Bap. These results
confirmed that Gp96 serves as a ligand for native Bap in intact
bacteria. Third, the specificity of the Gp96binding to Bap was
further validated by the ability of polyclonal anti-Bap antibodies
to block the binding of Gp96 to Bap producing bacteria
(Figure 4B).Fourth, as Bap homologues have been identified in
several staphylococcal species including S. epidermidis, S.chromogenes
and S. hyicus [29], we investigated whether Bap homologous
proteins were also able to interact with Gp96. For that, live intact
S. epidermidis C533, S. hyicus 12and S. chromogenes C483 bacteria
were incubated with recombinant Gp96 protein and binding of
Gp96 was detected by western-blot using anti-Gp96. As shown in
Figure 4C, all the coagulase negative staphylococcal strains
producing Bap proteins were capable of pulling down Gp96
indicating that all Bap homologous proteins produced by
different coagulase negative staphylococcal species interact with
Gp96.
Bap mediated adhesion to epithelial cells is independent
of the presence of Gp96
To investigate whether the interaction of Bap with Gp96 was
responsible for the Bap-mediated adhesion of S. aureus to
epithelial cells, we measured the adhesion of S. aureus to Hep-
3B cells after knocking down the Gp96 message by siRNA. The
efficiency of Gp96 down regulation was determined by densi-
tometry of Gp96 immunoblots using anti-Gp96 antibodies. As is
shown in figure 5A, transfection of Gp96 specific siRNA duplexes
consistently resulted in a 90% reduction in Gp96 protein levels
compared to the nontransfected cells or to the cells transfected
with control siRNA. The specific silencing of Gp96 expression
was further confirmed by the lack of effect of Gp96 siRNA on the
fibronectin protein. However, inhibition of Gp96 expression had
no significant effect on the adhesion of Bap producing bacteria,
suggesting that Gp96 was not required for Bap-mediated
adhesion (Figure 5B).Additional evidence that Gp96 was not
required for S. aureus adhesion to epithelial cells was obtained by
assessing the adhesion of S. aureus V329 and Dbap to the Gp96
deficient cell lines, Vero and GPC-16. The results revealed that
the V329 strain still adhered significantly more efficiently
(P,0.05) than the Dbap mutant to both cell lines, indicating that
the interaction of Bap with Gp96 was not required for the Bap-
mediated adhesion to epithelial cells (Figure 5C).
Bap and Gp96 interaction inhibits the entry of S. aureus
into epithelial cells
We next examined a plausible role of the interaction of Bap
with Gp96 in the invasion of S. aureus into epithelial cells. For that,
we first determined the entry of S. aureus V329 and Dbap to the
Gp96 deficient cell lines, Vero and GPC-16. The results showed
no significant differences between bacteria expressing Bap and the
Dbap mutant (Figure 6A), suggesting that the presence of Gp96 on
the cell membrane is necessary for Bap-mediated inhibition of
cell invasion. To confirm this, we carried out invasion assays on
Vero cells producing Gp96 from a pcDNA3 vector containing
gp96 cDNA [56] (Figure 6B).The presence of Gp96 signifi-
cantly reduced (P,0.05) the capacity of S. aureus V329 (Bap+) to
invade the cells whereas it did not have any significant effect on
the entry of Dbap deficient bacteria(Figure 6C).These results
Figure 4. Bap binds the cellular receptor Gp96. A) For the co-
immunoprecipitation (Co-IP) recombinant Gp96 was incubated with
purified Bap protein and immunoprecipitated with anti-Bap and protein
G sepharose beads. In the control assay, the incubation step with Bap or
Gp96 was omitted. Immunoprecipitated proteins were separated in
10% SDS gel, transferred onto a nitrocellulose membrane and probed
with anti-Gp96 (a-Gp96) or anti-Bap (a-Bap). B) Recombinant Gp96
binds to S. aureus expressing Bap. Bacteria expressing Bap (V329) and
the Bap deleted mutant (Dbap) were subcultured with 5 mg/ml of
recombinant Gp96 in the absence or presence of anti-Bap serum as
indicated. Unbound Gp96 was removed by extensive washing and
Gp96 bound to bacteria was detected using immunoblot analysis. C)
Bap proteins of coagulase negative staphylococci(S. epidermidis C533, S.
hyicus 12, S. chromogenes C483) bind Bap. Bacteria were subcultured
with 5 mg/ml of recombinant Gp96. Unbound Gp96 was removed by
extensive washing and Gp96 bound to bacteria was detected using
immunoblot analysis (upper part). Bap expression in S. epidermidis
C533, S. hyicus 12, S. chromogenes C483 by immunoblot using
polyclonal anti-Bap (a-Bap) serum (lower part).
doi:10.1371/journal.ppat.1002843.g004
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confirmed that it is the interaction of Bap with Gp96 and not
the fact that Bap producing bacteria are merely coated in a
matrix, which reduces the capacity of S. aureus to invade
epithelial cells. Finally, we determined the entry of S. aureus in
Hep-3B cells after knocking down the expression of Gp96 by
siRNA (Figure 6D). The number of intracellular S. aureus V329
increased significantly (P,0.05) when the expression of Gp96
was inhibited(Figure 6E). Taken together, these results indicate
that the interaction of Bap with Gp96 inhibits the entry of S.
aureus into epithelial cells.
Bap-Gp96 interaction interferes with FnBPs mediated
entry of S. aureus in epithelial cells
We next investigated the mechanisms by which the Bap-Gp96
interaction was inhibiting the entry of S. aureus into the host cell.
To this end, we first analyzed whether Bap-Gp96 interaction was
affecting the signaling pathway downstream Gp96.For that, we
blocked Gp96activityand therefore the downstream signaling
pathway by incubating the cells overnight in the presence of 17-
AAG (17-(Allylamino)-17-demethoxydeldanamycin), which binds
with high affinity into the ATP binding pocket of Gp96. The
results revealed that the presence of 17-AAG (1 mM) did not affect
S. aureusV329 entry (Figure 7A). To confirm these results and also
to rule out the possibility of an indirect effect of the Gp96 absence
on the expression of other Bap receptors we transcomplemented
Gp96 deficient cells with purified soluble Gp96 and analyzed the
infection rates of S. aureus V329 and Dbap. Addition of soluble
Gp96 prior to infection significantly reduced the entry of S. aureus
V329 into Vero cells and this reduction was even higher when
bacteria were preincubated with recombinant Gp96 before
infection (Figure 7B). In contrast, the entry of the Bap deficient
strain was not affected by the preincubation with Gp96 (Figure 7B).
Together, these results indicate that the inhibition of S. aureus entry
caused by Bap-Gp96 interaction is neither due to an interference
with the Gp96 signaling pathway nor to a blockage of Bap binding
to other cell receptors.
In cell culture models, invasion of non-professional phagocytic
cells by S. aureus depends on the presence of FnBPs on the
bacterial surface, and fibronectin and integrins on the host cell.
FnBPs are important not only for adhesion but also for activating
host-cell cytoskeletal remodeling via integrin-coupled signaling
[57–63].We thus investigated the hypothesis that Bap-Gp96
interaction might be somehow interfering with the FnBPs-
mediated invasion process. To this end, we deleted both fnbA
and fnbB genes(Dfnb) in both S. aureus V329 and in the Dbap
mutant. As shown in figure 7C, the wild type strain and its
mutant in fnbAB showed a similar infection rate, whilst deletion of
FnBPs counteracted the increased invasion capacity shown by the
S. aureus V329 Dbap. To further explore this question, we made
use of S. aureus Newman strain that is deficient in the production
of FnBPs [64] and consequently presents a very low invasion rate.
As expected, complementation of this strain with plasmid
pFNBA4 that expresses the fnbA gene significantly enhanced its
entry capacity into MAC-T cells. Notably, when the bap gene was
expressed from the chromosome of this fnbA complemented
strain, the invasion rate decreased significantly (Figure 7D). To
confirm the requirement of Gp96 in the masking effect on FnBPs-
mediated internalization process activity, similar experiments
were carried out in Vero cells transfected with pcDNA3gp96.A-
gain,reductionof FnBPs-mediated invasion of Bap producing
bacteria only occurred when Vero cells were producing Gp96
(Figure S2). Taken together, these results suggest that Bap-Gp96
interaction interferes with FnBPs-mediated entry of S. aureus in
epithelial cells.
A shorter allele of Bap exhibits a low capacity to inhibit
FnBPs-mediated bacterial invasion
As Bap is a large protein of 2276-amino-acid we wondered
whether the interaction of Bap with Gp96 could act as a steric
hindrance, limiting the accessibility of FnBPs to its target,
fibronectin, and in consequence minimizing cell entry. To further
assess this hypothesis we constructed a S. aureus strain that
produces a recombinant short Bap protein, containing a single
repetition (DrepBap), and leading to a Bap derivative about half
Figure 5. Bap mediated adhesion is independent of Gp96. A)
Hep-3B cells were transfected with control (siRNA-Ct), silencer gp96
(siRNA-gp96) or nontransfected (w) for 18 h. Gp96 expression was
analyzed by western-blot using anti-Gp96 antibodies (a-Gp96) followed
by signal quantification with ImageJ software. Right panel shows the
levels of fibronectin expression of transfected cells. Adhesion of S.
aureus V329 wild type (Wt) and Bap deficient strain (Dbap) on Hep-3B
cells transfected with control (siRNA-Ct) or silencer gp96 (siRNA-gp96)
(B) or to Vero and GPC-16 cells that do not express Gp96 at the cell
surface (C). After 1 h of infection, cells were lysed and cell extracts were
vigorously vortexed for 2 min. Bacterial adhesion was measured by CFU
counts. Error bars represent the standard deviation of at least 3
independent experiments.
doi:10.1371/journal.ppat.1002843.g005
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the size of the wild type protein (Figure 8A). Western-blot analysis
using anti-Bap antibodies confirmed that S. aureus DrepBap strain
produced similar levels of the short Bap protein compared to
wildtype strain (Figure 8B). Moreover, the biofilm formed by S.
aureus DrepBap strain was indistinguishable from that produced by
V329 strain indicating that the short Bap variant is functional
(Figure 8 C).
Then, we investigated whether DrepBap still retained the
capacity to interact with Gp96 using the pull-down assay. As
shown in figure 8D, Gp96 was pulled down by intact cells
producing DrepBap as efficiently as bacteria producing wildtype
Bap, indicating that a Bap allele containing a single repetition can
interact with Gp96. S. aureus DrepBap strain was then tested for its
ability to invade epithelial cells. The efficiency of entry of S. aureus
producing a DrepBap-mediated biofilm matrix was significantly
higher than that of wildtype bacteria and very similar to that of the
Bap deficient strain (P,0.05) (Figure 8E). Together these data
indicate that a short version of Bap, although still able to interact
with Gp96, is unable to block the infection capacity of wild type
bacteria, and thus support the hypothesis that the interaction of
Bap with Gp96 might cause a stearic impediment that interferes
with the FnBPs binding to fibronectin.
Figure 6. Bap-Gp96 interaction reduces the entry of S. aureus to epithelial cells. A) Invasion of S. aureus V329 wild type (Wt) and Bap
deficient strain (Dbap) into naturally Gp96-depleted Vero and GPC-16cells. Bacterial invasion was measured by CFU count after 2 h of gentamicin
treatment. Experiments were repeated in triplicate four times for each cell line. B) Vero cells were transfected with the pcDNA3 vector containing
gp96 DNA. Expression of Gp96 was determined by western-blot analysis of cell surface proteins. Surface exposed proteins were labelled with sulpho-
N-hydroxysuccinimide (NHS) biotin and purified using streptavidin columns. Captured proteins were separated in 10% SDS gel, transferred onto a
nitrocellulose membrane and probed with anti-Gp96 (a-Gp96) serum. C) Entry of S. aureus V329 wild type and Dbap mutant to Vero nontransfected
cells (w) and transfected with pcDNA3gp96 was analyzed by gentamicin assay. Bacteria entry was measured by CFU count after 2 h of gentamicin
treatment. D) Silencing Gp96 increases S. aureus V329 invasion. Hep-3B cells were transfected with 25 nM of control siRNA (siRNA-Ct), gp96 siRNA
(siRNA-gp96) or nontransfected (w). Gp96 expression was analyzed by western-blot using anti-Gp96 antibodies (a-Gp96) followed by signal
quantification with imageJ software. Right panel shows the levels of fibronectin expression of transfected cells. E) Hep-3B cells transfected with
control siRNA-Ct and siRNA-gp96 were examined for invasion of S. aureus V329 and Bap deficient strain (Dbap). Bacterial invasion was measured by
CFU count after gentamicin assay. Error bars represent the standard deviation of at least 3 independent experiments.
doi:10.1371/journal.ppat.1002843.g006
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Bap hinders S. aureus mammary gland invasion in a
lactating mouse mastitis model
To investigate the relevance of the Bap-dependent biofilm
matrix in the prevention of in vivo host cell invasion we used a
lactating mouse mastitis model. We first confirmed that Gp96 is
expressed in mammary glands of lactating mice by western-blot
using anti-Gp96 antibodies (Figure 9A). Two mammary glands (L4
and R4) of a group of 7 lactating mice were inoculated with a
bacterial solution containing 106 CFU of S. aureus V329 (Bap+)
and bap::tet strains. After 18 h post-infection mammary glands
were treated 3 h with a solution of PBS containing gentamicin to
remove all the extracellular bacteria. Then, the mammary glands
were removed aseptically, homogenized and several dilutions were
plated on selective agar. To evaluate the invasion capacity of each
strain we used the competition index method. As a previous
control, we first verified that the invasion differences detected in-
vitro between the wild-type and the bap-deficient strain were
maintained when both strains were used to co-infected MAC-T
cells (Figure S3).In agreement with in vitro assays, wild type
bacteria producing Bap showed a significantly lower capacity to
invade the mammary gland cells compared with Bap deficient
bacteria (Figure 9B). Next, the experiment was repeated compar-
ing the in vivo invasion capacity of Bap deficient bacteria and the
strain expressing a short Bap derivative. These two strains showed
a very similar capacity to invade mammary gland cells (Figure 9B).
These results again confirmed in vitro results showing that the entry
efficiency of S. aureus producing a DrepBap-mediated biofilm
matrix is equal to that of the Bap deficient strain. Together, these
results strongly suggest that full-size Bap acts as anti-invasion
factor of the mammary gland in vivo.
Discussion
Biofilm formation is recognized as causing or exacerbating
several S. aureus chronic infections such as osteomyelitis, endocar-
ditis and device related infections. The molecular mechanisms
Figure 7. The expression of Bap minimized S. aureus cell entry by interfering with the FnBPs. A) Evaluation of the effect of 17-AAG on the
invasion phenotype mediated by Bap. MAC-T cells were treated overnight with 1 mmol/l of 17-AAG, an inhibitor of HSP90. Invasion assays were then
carried out with either S. aureus V329 and Dbap strain. Internalized bacteria were determined by CFU count after gentamicin assay. B)
Transcomplementation of Vero cells with Gp96. Invasion assay with S. aureus V329 and Dbap was performed in Vero cells (w), in Vero cells incubated
with 10 mg/ml of recombinant Gp96 for 30 min before infection (Cells+Gp96) or with bacteria pre-incubated with 5 mg/ml of recombinant Gp96
(Bacteria+Gp96). C)Inhibition of bacterial invasion mediated by Bap requires the FnBPs. Invasion of S. aureus V329 wild type (Wt), a mutant in FnBPs
(Dfnb), Dbap and double mutant DfnbDbap. After 1 h infection invasion values were calculated as the number of bacteria that survived to 2 h of
gentamicin treatment in MAC-T cells.(D) MAC-T cells invasion with S. aureus Newman (Nw) and Newman_Bap complemented with plasmid pFNBA4
that expresses the fnbA gene. Experiments were performed in triplicate and repeated three times.
doi:10.1371/journal.ppat.1002843.g007
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underlying the persistence of biofilm infections have been mainly
associated with the protection barrier that the biofilm matrix
provides against the host immune response and the antibiotic
treatments to the embedded bacteria. For example, exopolysac-
charidic PIA/PNAG biofilm matrix protects S. aureus from
phagocytosis by polymorphic neutrophils and from antibodies
mediated opsonisation and retards the rate of antibiotic penetra-
tion enough to induce the expression of genes that mediate
resistance [32,65–67].
With the aim to identify new functions for the biofilm matrix
that may facilitate the development of persistent infections, we
have investigated the role of the proteinaceous Bap-mediated
biofilm matrix in the interaction with host cells. Our results
provide evidences that the Bap biofilm matrix promotes the
adhesion of S. aureus to different types of epithelial cells. For this
function, Bap does not require the participation of any other
staphylococcal factors, because production of Bap in E. faecalis is
sufficient to bestow the capacity to adhere to epithelial cells.
Screening for the specific molecular target on the epithelial cells
using a ligand immunoblot overlay approach revealed that Bap
binds to Gp96, also known as GRP94 or endoplasmin, which is a
major chaperon of the lumen of the endoplasmic reticulum (ER)
[42,43,68]. We initially received this result with caution because,
using the same approach, Gp96 had been previously identified as
the ligand for Vip, a surface protein of Listeria monocytogenes without
homology with Bap [52]. To exclude that Bap might be
interacting with Gp96 in an artificial way, confirmatory pull
down studies were carried out. The results revealed that (i)
recombinant Gp96 was pulled down with native Bap protein
anchored to the cell wall of intact bacteria; (ii) recombinant Gp96
was pulled down with soluble Bap and anti-Bap antibodies; and
(iii)anti-Bap antibodies were able to inhibit the interaction between
Bap and Gp96. Another caution about Gp96 being the ligand for
Bap was that Gp96 was initially described as an endoplasmic
reticulum (ER) protein based on the presence of the KDEL motif
in the carboxy-terminal domain of the protein [47,69,70].
However, in agreement with other studies [45–50,52,54,55], we
have found that Gp96 is not restricted to the ER and is also
present on the surface of some epithelial cell lines (Hep-3B and
MAC-T).
Figure 8. Effect of Bap repetitions in Gp96 interaction and cell invasion. A) Structural organization of Bap with or without repetitions. SP,
signal peptide; A, region A; B, region B; C, repetition region; D, region of serine-aspartate (SD) repeats; MA cell wall anchor. B) Western-blot analysis
with anti-Bap (a-Bap) serum of surface protein preparations obtained under isosmotic conditions from S. aureus V329 (Bap+), Dbap and DrepBap
(truncated Bap). C) Biofilm phenotypes of S. aureus V329, Dbap and DrepBap. Congo red morphology on congo red agar plates and biofilm formation
in microtiter plates. D) Interaction of Bap-truncated protein with Gp96. S. aureus V329 (Bap+), Dbap and DrepBap strains were subcultured with 5 mg/
ml of recombinant Gp96. Unbound Gp96 was removed by extensive washing and Gp96 bound to bacteria was detected using immunoblot analysis.
E) Entry of S. aureus V329, Dbap and DrepBap strains was analyzed by gentamicin assay in MAC-T and Hep-3B cells. Experiments were performed in
triplicate and repeated three times for each cell line.
doi:10.1371/journal.ppat.1002843.g008
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Given that Bap was interacting with Gp96 and promoting
adherence to epithelial cells, we hypothesized that binding of Bap
to Gp96 might be responsible for the enhanced adherence of Bap
producing bacteria to the surface of the epithelial cells. In contrast
to our assumption, we found that depletion of Gp96 expression by
siRNA in Hep-3B cells did not reduce the adhesion capacity of
Bap positive bacteria. Furthermore, bacteria producing Bap also
displayed a higher capacity to adhere to cells that do not produce
Gp96 than Bap deficient bacteria, indicating that Bap was
interacting with another factor, different from Gp96, to promote
the adhesion to the epithelial cells. These results raised the
question as to why this receptor was not identified with the ligand
overlay experiment. At least two reasons can be envisioned to
explain this failure. Either the ligand is not a protein and/or Bap
might recognize its ligand only in its native folded structure.
Further experiments will be needed to identify this additional
cellular ligand.
On the other hand, we have shown that the interaction of Bap
with Gp96 inhibits bacterial entry into epithelial cells. Several
results support this conclusion: (i) Bap deficient bacteria showed
higher levels of invasion than the corresponding wildtype strain in
cells producing Gp96; (ii) the invasion differences between Bap
positive and negative strains disappeared when invasion was tested
inGp96 negative cells; (iii) the entry of Bap positive bacteria
decreased in cells overproducing Gp96 and increased in cells
depleted of Gp96 by the expression of siRNA; (iv) preincubation of
cells or bacteria with soluble Gp96 inhibited the S. aureus entry into
the cells. These former results also indicate that Bap does not need
to interact with membrane anchored Gp96 to inhibit bacterial
entry. How does the interaction between Bap and Gp96 interfere
with S. aureus invasion? We initially explored the possibility that the
binding of Bap with Gp96 might interfere with the signaling
pathway downstream Gp96. Against this hypothesis, we have
shown that treatment of MAC-T and Hep-3B cell with 17-AAG, a
drug that affects the signaling pathway regulated by Gp96, does
not affect the invasion levels of Bap producing bacteria.
Furthermore, incubation of Vero cells with soluble Gp96, which
is not linked with the cytoplasmic partners, still reduced the
capacity of S. aureus to invade the cells. Alternatively, the
interaction of Bap with Gp96 could be directly interfering with
the recognition of another host ligand. The main known
mechanism of S. aureus invasion into the host cell is mediated by
the bacterial fibronectin binding proteins, FnBPA and FnBPB and
host cell fibronectin anda5b1 integrins [57–63].Our results suggest
that the interaction of Bap with Gp96 interferes with the FnBPs-
fibronectin-integrin invasion pathway because deletion of FnBP
proteins counteracted the increased invasion rates of Bap deficient
bacteria. In addition, overexpression of FnBPs restored the
invasion capacity of Bap negative bacteria but did not change
the decreased invasion capacity of Bap producing bacteria. It is
worth noting that the interference of the FnBPs invasion pathway
depends on the length of Bap, because a short but still functional
allele of Bap displayed a significantly lower efficiency than the full-
length protein to inhibit bacterial entry.
Gp96 has been reported to be the ligand for various bacterial
surface proteins, though the consequences of this interaction seem
to be different depending on the bacteria [52,53,55,56,71–73].
The bacterial Outer membrane protein A (OmpA) of Escherichia
coli interacts with Ecgp96, an homolog of Gp96 that is highly
expressed in brain microvascular endothelial cells during menin-
gitis infection, and induces bacterial invasion [56,71,72]. Also,
Cabanes et al. [52]identified that the interaction of Vip with Gp96
promotes Listeria monocytogenes invasion of the cell. Gp96 has also
been described to interact with other bacterial products such as the
exotoxin A (TxA) of Clostridium difficile [74]and the outer
membrane vesicles (OMVs) produced by adherent-invasive E. coli
(AIEC) promoting bacterial invasion [55]. In contrast, the
interaction of the outer membrane porin PorBIA of Neisseria
gonorrhoeae with Gp96 inhibits bacterial invasion [53]. Moreover,
the interaction of Hsp90 (a chaperone homolog to Gp96) with the
trimeric surface protein NadA also interferes with bacterial
adhesion and invasion [73]. It is worth noting that OmpA, Vip,
PorB and NadA do not show any homology with Bap that would
explain the interaction with the same ligand. One may speculate
that Gp96 is able to bind unspecifically to these bacterial proteins
due to its chaperone structure. However, pull down and ligand
overlay assays with bacteria producing two other members of the
Bap family (Esp protein of Enterococcus faecalis and BapA from
Salmonella Enteritidis) or an unrelated bacterial protein (dispersin)-
did not show any interaction with Gp96 (data not shown),
excluding the hypothesis that Gp96 can interact with any bacterial
protein. Also, these results indicate that not all the members of the
Bap family can interact with Gp96 protein.
The presence of Bapin S. aureus is specifically enriched, by yet
unknown reasons, in mastitis-derived isolates where Bap facilitates
the persistence of the bacteria in lactating ewes mammary glands
[30]. Bap homologous proteins are also encoded in different
coagulase negative staphylococcal species associated with chronic
mastitis infections [75–77].Gp96 is expressed in the bovine
mammary glands during the lactating period (Figure 9A) and its
Figure 9. Effect of Bap expression in S. aureus invasion into
mammary glands using a murine mastitis model. A) Gp96
expression in mammary glands L4 and R4. Glands were homogenized
and proteins were resolved by 10% SDS-polyacrylamide gels. Gp96 was
detected using anti-Gp96 antibodies. B) Competition indexes of Dbap-
Wt and Dbap-DrepBap. Mice mammary glands were coinfected with
equal numbers of the strains tested. After 18 h post-infection mammary
glands were treated (intra-mammary administration) with PBS with
gentamicin for 3 h. Bacterial counts (CFU) were obtained from each
mammary gland. Competition indexes were calculated and statistical
differences were determined with a t-test. Horizontal bars represent the
means of the competition indexes. Asterisks indicate that competition
indexes are significantly greater than one (**, P,0.01 [very significant]).
ns, non significant differences.
doi:10.1371/journal.ppat.1002843.g009
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presence in the milk has been suggested to be a host defense
mechanism [78]. In the present study, we have found a connection
between these two findings using a lactating mice infection model,
where the Bap expression had a profound impact on the capacity
of the bacteria to adhere and invade the mammary gland epithelial
cells. Overall, our results support the view that Bap mediated
biofilm development facilitates the formation of bacterial aggre-
gates that survive attached to the epithelial cells of the mammary
gland by impairing the bacterial internalization through the
interaction with Gp96. In this situation, the Bap biofilm matrix
promotes the establishment of long-term persistent infections and
mediates immune evasion by masking surface antigens. Whether
the proteinaceous Bap-dependent biofilm matrix of different
bacterial species is playing a similar role in the interaction with
the host cells is worthy of further exploration.
Materials and Methods
Ethics statement
All animal studies were reviewed and approved by the ‘‘Comite´
de Etica, Experimentacio´n Animal y Bioseguridad’’ of the
Universidad Pu´blica de Navarra (approved protocol PI-6/10).
Work was carried out at the Centro de Agrobiotecnologı´a building
(Idab) under the principles and guidelines described in the
‘‘European Directive 86/609/EEC’’ for the protection of animals
used for experimental purposes.
Bacterial strains, cell culture and culture conditions
Escherichia coli DH10B was cultured in Luria-Bertani (LB) media
or on LB agar (Pronadisa, Spain) with appropriate antibiotics.
Staphylococcal strains were grown in Trypticase soy broth (TSB)
or Trypticase soy agar (TSA) supplemented with glucose 0.25%
(TSB-glu) when indicated. Media were supplemented with the
following appropriate antibiotics at indicated concentrations:
erythromycin 20 mg ml21 or 1.5 mg ml21, chloramphenicol
20 mg ml21, ampicillin 100 mg ml21, tetracycline 10 mg ml21.Bo-
vine mammary gland epithelial cell line (MAC-T) was used
because bap gene is frequently present in S. aureus isolates causing
mastitis infections. Human hepathoma cell line (Hep-3B, ATCC
number CCL-2) was used as an example of any other cell line
different from mammary gland epithelial cells. Vero epithelial cells
(ATCC number CCL-81) and guinea–pig GPC-16 epithelial cells
were used due to their low extracellular Gp96 expression [52].
Cells were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) (Gibco-BRL) supplemented with 10% heat-inactivated
fetal bovine serum (Gibco-BRL).
Manipulation of DNA
To generate the deletion in the bap gene we amplified by PCR
two fragments of 500 bp that flanked the left sequence of the gene
using primers Dbap-A (ggatccgacatacattagatatttgg) and Dbap-B
(ctcgagcaattttatgacgcactatt) and the right sequence of bap using
primers Dbap-C (ctcgagcccattttattattggttctg) and Dbap-D
(gaattcgccgaaatgttggccgtattc). Fragments were then fused by
ligation into the shuttle vector pMAD, and the resulting plasmid
was transformed in V329 strain by electroporation. Allelic
exchange in the absence of a selection marker was performed as
previously described [27]. FnBPs mutant in V329 and Dbap strains
was performed as previously described [17]. To generate the
DrepBap strain, the bap gene of S. aureus V858 whose bap contains a
single C-repeat was amplified using DNA polymerase KOD XL
(Merck) with primers BapXho-5 (ctcgagtaaaaaaatttattttgaggtgag)
and BapXho-3 (ctcgagctctccacctttgtaagtg). The gene was cloned
into the pMAD plasmid and the resulting plasmid was
transformed into Dbap strain by electroporation. Allelic exchange
in the absence of a selection marker was performed as previously
described [27]. DrepBap strains were verified using primers Bap-6m
(cctatatcgaaggtgtagaattgcac) and Bap-7c (gctgttgaagttaatactg-
tacctgc).
S. aurues bap::tet strain was constructed using plasmid pJP188
[79].For complementation experiments, the multicopy plasmid
pFNBA4 [80] that carries the wild-type fnbA gene of S. aureus8325-
4 was used. E. faecalis 23 was complemented with plasmid pBT2-
bap.
Generation of purified Bap recombinant protein
For Bap purification we constructed a recombinant Bap protein
in which the LPXTG motif of Bap was replaced by the 6-histidine
tag. For that, a 281 bp fragment upstream the LPXTG was
amplified using primers BapEco-A (gaattcaattcaggtgctggagacac)
and BapBam-B (ggatcctcagtggtggtggtggtggtgttctggtaattcattttg). A
600 bp fragment downstream Bap was amplified using primers
BapBam-C (ggatccatgtttaaattattgtaaat) and BapEco-D (gaattcgcc-
gaaatgttggccgtattc). Fragments were cloned into the EcoRI site of
the pMAD plasmid [81]and the resulting plasmid was transformed
into V329 strain by electroporation using a previously described
protocol [30]. The construction was verified by sequencing the
insert. Allelic exchange in the absence of a selection marker was
performed as previously described [27]. As the LPXTG motif was
replaced by the 6xHis tag, the recombinant Bap-6xHis protein was
obtained at the supernatant. One liter of the supernatant was
concentrated using centrifugal filter units 10,000 wco (Millipore).
Bap-6xHis tagged protein was purified from the supernatant using
His GraviTrap affinity columns (GE Healthcare).
Ligand overlayer assay
MAC-T and Hep-3B epithelial cells were lysed in RIPA-buffer
(150 mM NaCl, 50 mM Tris pH7.5, 0.1% SDS, 1% Triton X-
100, 0.5% sodium deoxycholate, 1 mM sodiumorthovanadate,
10 mM NaF, b-glycerophosphate 100 mM and protease inhibitor
cocktail (Roche)). Lysates were clarified and protein concentration
was determined. 40 mg of cell lysates were resolved by 10% sodium
dodecyl sulphate (SDS)-polyacrylamide gel electrophoresis. Pro-
teins were transferred onto a nitrocellulose membrane and blocked
overnight. The membrane was then incubated with 50 mg/ml of
purified Bap, washed and incubated with anti-bap antibodies
diluted 1:20,000 [30]. Alkaline phosphatase-conjugated goat anti-
rabbit immunoglobulin G diluted 1:10,000 was used as secondary
antibody. Protein identification was analyzed by MALDI-TOF
analysis followed by peptide mass fingerprinting [16].
Pull-down assays
10 mg of the recombinant Gp96 protein (SPP-766 Stressgen)
were mixed with 10 mg of purified Bap. The mix was incubated at
4uC for 2 h in slow agitation. Gp96 was immunoprecipitated using
1.5 ml of anti-Bap antibodies, for 2 h at 4uC and then with 50 ml of
Protein G sepharose beads (GE Healthcare). Immunoprecipitated
proteins were boiled in Laemmli buffer and analyzed by SDS-
polyacrylamide gel electrophoresis, inmmunoblotted with primary
antibodies anti-Bap (1:2500) or anti-Gp96 (1:1000)monoclonal
antibodies (SPA-850 Stressgen)and with secondary antibodies goat
anti-rabbit immunoglobulin-G HRP (Thermo) or anti-rat immu-
noglobulin-G HRP (SAB-200 Stressgen). Pull down experiment
using bacteria was performed as follows. S. aureus V329 expressing
Bap, Dbap, DrepBap and CNS(S. epidermidis C533, S. hyicus 12, and
S. chromogenes C483) were grown overnight at 37uC. A volume of
cells corresponding to an OD600 value of 5 was centrifuged and
washed twice with PBS buffer. Bacteria were then incubated with
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5 mg/ml of recombinant Gp96 protein in the absence or in the
presence of anti-Bap antibodies for 2 h at 4uC and slow agitation.
Unbound Gp96 was removed by washing the bacteria 4 times with
1 ml of PBS buffer. Immunoprecipitated Gp96 was detected using
anti-Gp96 antibodies and anti-rat immunoglobulin-G HRP.
Biofilm phenotype
Biofilm formation assay in microtiter wells was performed as
described [18]. Briefly, strains were grown overnight at 37uC and
were diluted 1:40 in TSB-gluc. Cell suspension was used to
inoculate sterile 96-well polystyrene microtiter plates (IWAKI).
After 24 hours at 37uC wells were gently rinsed three times with
water, dried and stained with 0.1% of crystal violet for 15 min.
Colony morphology of S. aureus was analyzed using Congo red
agar plates [82–84].Congo red agar was prepared as follow: 30 g/l
of trypticase soy (Pronadisa), 15 g/l of agar (Pronadisa), 0.8 g/l of
Congo red stain (Sigma) and 20 g/l of sucrose. The Congo red
stain and the sucrose solution were autoclaved separately (121uC
for 20 minutes) and (115uC for 15 minutes) respectively. S. aureus
strains were streaked on congo red agar and were incubated at
37uC for 24 hours. Rough colonies are being indicative of biofilm
formation.
Epithelial cell adhesion and invasion assays
Adherence and invasion experiments were performed as
described previously [57]. Briefly, prior to use, wells were seeded
with 0.36106 cells in 6-well tissue culture plates and 0.56105 cells
in 24-well tissue culture plates. Once cells were confluent (1.26106
or 0.2 106 cells per well) the culture medium was removed and
cells were washed with DMEM plus 10% heat-inactivated fetal
bovine serum. For adherence assays, overnight bacterial cultures
were mixed vigorously and added to the monolayer cells in a
multiplicity of infection of 10 in DMEM. Incubation was carried
out 1 hour at 37uC in 5% CO2. To remove non-adherent
bacteria, cells were washed three times with sterile PBS.
Eukaryotic cells were lysed with 0.1% Triton X-100. Before
plating extracts were mixed vigorously by vortexing and sonica-
tion. The number of adherent bacteria were determined by serial
dilution and plating. For invasion assays, bacteria were added to
the monolayer cells in a multiplicity of infection of 40 in DMEM.
Incubation was carried out for 1 hour at 37uC in 5% CO2. To kill
extracellular bacteria, media was replaced with 2 ml of DMEM
containing 50 mg ml21 of gentamicin (SIGMA) for 2 hour. Cell
monolayers were washed three times with sterile PBS and lysed
with 0.1% Triton X-100. Before plating extracts were mixed
vigorously by vortexing and sonication. The number of intracel-
lular bacteria was determined by serial dilution and plating.
Experiments were performed in triplicate.
Cell surface protein biotinylation
Cell surface biotinylation was performed using Pierce Cell
surface protein isolation kit according to the manufacturer’s
protocol. Briefly, 4 flasks of 75 cm2 of live confluent cells were
incubated with Sulfo-NHS-SS-Biotin for 30 min at 4uC. Sulfo-
NHS-SS-Biotin was quenched and biotinylized cells were lyzed.
For isolation of labelled proteins lyzed cell were incubated with
NeutrAvidin Agarose. Eluted proteins were resolved by 10%
sodium dodecyl sulphate (SDS)-polyacrylamide gel electrophore-
sis. Immunodetection was performed following protein transfer
onto nitrocellulose membrane and incubation with anti-Gp96
antibodies. To control membrane impermeability a-catenin was
detected using anti-a-catenin antibodies (H-297 Santa Cruz
Biotechnologies).
Immunofluorescence analysis
Cells grown on coverslips, fixed with paraformaldehyde 3.5%
(SIGMA) and stained with anti-Gp96 (H-212; Santa Cruz Biotech)
diluted 1:100 and stained secondary antibody Alexa Fluor 488-
conjugated goat anti-rabbit (Invitrogen). Cells were then permea-
bilized (0.1% triton X-100 for 5 min in PBS). Alexa-Fluor 647-
Phalloidin (Invitrogen) diluted 1:200 was used to label actin
filaments. Preparations were observed with an epifluorescence
microscope and images were acquired and analyzed with EZ-C1
software (Nikon).
Plasmid DNA and silencer gp96 transfections
Transient transfection of pcDNA3-gp96 in Vero cells was
performed using Lipofectamine 2000 (Invitrogen) following the
manufacturer’s protocol. Briefly, lipofectamine was diluted 1:25 in
DMEM media. Diluted lipofectamine was then mixed with 0.8 mg
of DNA in a 2:1 ratio and the mixture was incubated for 20 min at
room temperature. After incubation, 100 ml were added to a 24-
well culture vessel containing Vero confluent cells. To silence gene
expression by siRNA, Hep-3B cells were transfected with Gp96
silencer siRNA (Hs_TRA1_9) and control siRNA (Allstars
Negative Control) purchased from Qiagen (Valencia, CA).
Transfection was performed using a Ready-to-Use mix from
Qiagen as described by the manufacturer. Cells were collected for
immunodetection of Gp96 using monoclonal anti-Gp96 antibodies
and fibronectin using anti-fibronectin antibodies (SIGMA).Gp96
expression was determined by density measurement of digital
images using ImageJ software.
Treatment with 17-AAG and transcomplementation with
Gp96
MAC-T and Hep-3B monolayers were treated with 1 mM of 17-
(Allylamino)-17-demethoxydeldanamycin (17-AAG) or the vehicle
control DMSO, one day before the experiments. Overnight
treatments of MAC-T and Hep-3B had no effect on cell
morphology. Then, cells were washed and incubated with bacteria
for invasion assays. Transcomplemetation of Vero cells were
performed as described by Rechner et al., 2007 [53]. Briefly,
0.56106 Vero cells were incubated with 10 mg/ml of Gp96 for
30 min (cells+Gp96) and infected with S. aureus V329 and Dbap
strains (MOI = 40) to perform invasion assays. Additionally, S.
aureus V329 and Dbap strains were incubated with 5 mg/ml of
recombinant Gp96 protein for 2 h at 4uC. After washing bacteria
were used for infection of Vero cells (0.56106) (bacteria+Gp96).
Mice intramammary infection model
CD1 mice were maintained in the animal facility of the Institute
of Agrobiotechnology, Public University of Navarra. Seven to 10
days after parturition, pups of a group of 7 lactating female mice
were removed 2 h before bacterial inoculation. A mixture of
ketamine/xylazine was used to anaesthetize lactating mice. 100 ml
of a solution containing 106 CFU of a mix of S. aureus bap::tet and
V329 strains or a mix of bap::tet and DrepBap strains were used to
inoculate L4 (on the left) and R4 (on the right) mammary glands.
After 18 h post-infection L4 and R4 mammary glands were
inoculated with 200 ml of a solution of PBS containing
100 mg ml21 of gentamicin (SIGMA). After 3 h,L4 and R4
mammary glands were aseptically removed and homogenized.
Viable counts were performed on these homogenates by plating
the samples on TSA and TSA containing tetracycline. To evaluate
the invasion capacity of each strain we used the competition index
method. A competition index equal to 1 indicates similar
invasiveness for both strains. A competition index significantly
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greater than 1 indicates a higher invasion capacity of the Bap
mutant and a competition index lower than 1 indicates the
opposite. Prior to the start of the coinfection assays, a competition
experiment was performed with all strains tested to confirm that
coincubation of the strains did not affect their growth capacity.
Statistical analysis
Data corresponding to adhesion and invasion were compared
using the Mann-Whitney tests. Competition indexes of wild type-
Dbap and Dbap-DrepBap were calculated using t-test and statistical
differences were determined with the t-test.
Supporting Information
Figure S1 Effect of the presence of PIA/PNAG exopolysac-
charidic biofilm matrix in S. aureus invasion capacity. A) Dot-blot
analysis showing PIA/PNAG accumulation in S. aureus V329 and
Dbap complemented with pSC18 and S. aureus ISP479r. Cell
surface extracts were treated with proteinase K and spotted onto
nitrocellulose filters diluted 1/10. PNAG production was detected
with anti-S. aureus PNAG antiserum. Invasion of S. aureus V329,
V329 pSC18, Dbap mutant, Dbap pSC18, ISP479r and ISP479r
Dica into MAC-T (B) and Hep-3B (C) cells. Bacterial invasion was
measured by CFU count after 2 h of gentamicin treatment.
Statistical analyses were performed using Mann-Whitney tests.
(EPS)
Figure S2 Invasion of S. aureus Newman (Nw) and New-
man_Bap complemented with plasmid pFNBA4 that expresses
the fnbA gene to Vero cells and Vero cells transfected with
pcDNA3gp96. After 1 h infection invasion values were calculated
as the number of bacteria that survived to 2 h of gentamicin
treatment.
(EPS)
Figure S3 Competition index of Dbap-Wt and Dbap-DrepBap
strains in vitro. An equal number of bacteria of S. aureus V329 (Wt)
and Dbap or Dbap and DrepBap were used to infected MAC-T
epithelial cells. After 1 h infection, invasion efficiency was
calculated as the number of cfu that survived to 2 h of gentamicin
treatment. Statistical differences were determined with Mann-
Whitney tests. Horizontal bars represent the means of triplicates of
two independent experiments. Asterisks indicate differences in
competition indexes greater than one (P,0,05); ns, non-significant
differences.
(EPS)
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